Breast Screening Is Not Detrimental To The Survival Of Women With Interval Cancers

March 13, 1998

(Survival rates from interval cancer in NHS breast screening programme)

The NHS breast screening programme invites women aged 50-64 years for screening every three years. In this programme the term ëinterval cancer' is applied to a breast cancer occurring within the three years of a screening test with negative results. A higher than expected number of interval cancers have been reported to the NHS breast screening programme and there is conflicting evidence on whether the survival rates of women with interval cancers are different from those with breast cancers occurring in an unscreened population.

In this week's BMJ, Collins et al report on their study undertaken in North West England between 1988-91. Seventy three interval cancers and 565 cancers in women who were not screened, were diagnosed during the study period. The authors found that there was no significant difference between the survival rates of women in the two categories.

Collins et al conclude that although it is reassuring that breast screening has not been detrimental to the survival of those women who had interval breast cancers, minimising the occurrence of interval cancers must remain a high priority, if substantial reductions in mortality are to be achieved.

Contact:

Mr Stuart Collins, Information Scientist, Centre for Cancer Epidemiology, University of Manchester, Christie Hospital NHS Trust, Manchester
-end-


BMJ

Related Breast Screening Articles from Brightsurf:

Breast screening women in their forties saves lives
Breast screening women aged 40-49 reduces breast cancer mortality, with minimal increased overdiagnosis, according to a study led by Queen Mary University of London that looked at data from 160,000 women.

Screening mammography could benefit men at high risk of breast cancer
Selective mammography screening can provide potentially lifesaving early detection of breast cancer in men who are at high risk for the disease, according to a new landmark study.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

3D mammography detected 34 percent more breast cancers in screening
After screening 15 000 women over a period of five years, a major clinical study in Sweden has shown that 3D mammography, or breast tomosynthesis, detects over 30 percent more cancers compared to traditional mammography - with a majority of the detected tumors proving to be invasive cancers.

Breast cancer screening does not reduce mortality
Fewer and fewer women die from breast cancer in recent years but, surprisingly, the decline is just as large in the age groups that are not screened.

More breast cancers found with combined digital screening
A combination of digital mammography and tomosynthesis detects 90 percent more breast cancers than digital mammography alone, according to a new study.

Making individualized choices about breast cancer screening
The authors note, that despite the fact that the United States Preventive Services Task Force (USPSTF) changed its recommendation in 2009 to mammograms every two years for women aged 50-74 instead of annual mammograms beginning at age 40, there has been little change in US screening practices.

Average size of breast tumors decreased following introduction of screening but is now increasing
The average size of breast cancers at diagnosis decreased dramatically in the 1980s and 1990s following the introduction of screening, according to research presented at the 11th European Breast Cancer Conference.

Community practices not following guidelines for MRI breast cancer screening
Guidelines are not being followed to ensure that breast cancer screening of high risk women, such as those with a strong family history of breast cancer, includes an additional MRI (magnetic resonance imaging) scan.

Screening has had 'little impact' on falling breast cancer deaths in the Netherlands
Breast screening in the Netherlands seems to have had a marginal effect on breast cancer mortality over the past 24 years, suggests research in The BMJ today.

Read More: Breast Screening News and Breast Screening Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.